CO-CRYSTALS COMPRISING EPICATECHIN AND A CARBOXY-N-HETEROCYCLIC CO-CRYSTAL FORMER

Solid compositions of cocrystals of cannabinoids

Cyclic-di-AMP sodium salt crystal

Process for preparing Alectinib or a pharmaceutically acceptable salt thereof

CRYSTAL FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3) PYRIDAZINE-3-CARBOXAMIDE

TrkA Inhibitor

Crystalline form of LNP023

POLYMORPHIC AND AMORPHOUS FORMS OF ISOQUINOLINONE AND METHODS OF USE THEREOF

NOVEL SALT OF 4-({(4S)-1-(4-CARBAMIMIDOYLBENZOYL)-4-[4(METHYLSULFONYL)PIPERAZIN-1-YL]-L-PROLYL}AMINO) BENZOIC ACID AND NOVEL CRYSTAL FORM THEREOF

FERTILIZER COMPOSITIONS AND PLANTS CONTAINING PROTOCATECHUIC ACID, AND USES THEREOF

MEBENDAZOLE POLYMORPH FOR TREATMENT AND PREVENTION OF TUMORS

Methods of synthesizing substituted purine compounds

Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof

Process for the preparation of sodium (2R,5S,13AR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl) carbamoyl)-2,3,4,5,7,9,13,13A-octahydro-2,5-Methanopyrido[1 ′,2′:4,5]pyrazino[2,1 -b] [1,3] oxazepin-8-olate and its polymorphic form

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF

Compound of 3,3,3′,3′-tetramethyl-1,1′-spirobiindane-based bisoxazoline ligand, intermediate thereof, preparation method thereof and use thereof

Crystal form of tafamidis and preparation method therefor and use thereof

Polymorphs of pyrimidine cyclohexyl glucocorticoid receptor modulators

Crystalline (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate, compositions and methods of use thereof

Crystalline forms of eravacycline

CRYSTALLINE FORMS OF GFT-505, PROCESSES FOR PREPARATION AND USE THEREOF

Process for the preparation of Sugammadex sodium and its novel polymorphic form

Polymorph of echinocandin antifungal agent

Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl) phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl} pyrimidine-2,4-diamine

Polymorphic forms of bictegravir and its sodium salt

CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF

Crystalline forms of therapeutic compounds and uses thereof

METHODS OF PRODUCING NARONAPRIDE TRIHYDRATE

CRYSTAL FORM OF MALEATE OF TYROSINE KINASE INHIBITOR AND PREPARATION METHOD THEREFOR

NOVEL SALT OF A BCL-2 INHIBITOR, RELATED CRYSTALLINE FORM, METHOD FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

Solid forms of fasoracetam

CB-0406 choline salt

CB-0406 tromethamine salt

Production method for crystal of reduced coenzyme Q10 having excellent stability

Method for producing N-acetyl dipeptide and N-acetyl amino acid

Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof

Organotin clusters, solutions of organotin clusters, and application to high resolution patterning

Crystalline salts of corydalmine

Niraparib salts

Crystalline Forms of Niraparib Freebase

Processes for preparing a MDM2 inhibitor

CRYSTALLINE FORMS OF A FARNESOID X RECEPTOR AGONIST

4,5-DIHYDROXY-2-(4-METHYLBENZYL)ISOPHTHALONITRILE SOLVATES AND CRYSTALLINE FORMS THEREOF

Process of manufacture of a compound for inhibiting the activity of SHP2, as well as products resulting from acid addition

PROCESS FOR PREPARATION OF ERIBULIN AND INTERMEDIATES THEREOF

Crystalline forms of a triazolopyrimidine compound

Triazolopyrimidine compounds and their use in treating cancer

Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1- yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt

Small molecule inhibitors of the JAK family of kinases

SALT FORM AND CRYSTAL FORM OF NOVEL AZATRICYCLIC COMPOUND AND USE THEREOF

Inhibiting agents for Bruton's tyrosine kinase

Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide

Processes for the production of isomerically pure or enriched cis-clomiphene

Co-crystals of sodium benzoate and uses thereof

Oral compositions of MK2 pathway inhibitor for treatment of immune conditions

Cromolyn metal complexes as enhanced pharmaceutical formulations and method of preparing the same

SQUALAMINE SOLID FORMS AND METHODS OF MAKING THE SAME

CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer

Arginase inhibitors and methods of use thereof

Crystal of pyrazolo[3,4-d]pyrimidine

Crystalline forms of (S)-7-(1-(but-2-ynoyl)piperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

Hydrochloride salt forms of a sulfonamide structured kinase inhibitor

Morphic forms of complement factor D inhibitors

Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereof

CABOZANTINIB MALATE CRYSTAL FORM, PREPARATION METHOD AND USE THEREOF

Crystalline tranilast salts and their pharmaceutical use

Spray-dried dispersions, formulations, and polymorphs of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide

Human CGAS-DNA complex and encoded protein

Crystalline form of compound and uses thereof in medicine

CRYSTALS OF PYRANODIPYRIDINE COMPOUND

Polymorphs

METHODS FOR PURIFYING ISAVUCONAZONIUM SULFATE

Polymorphic forms of metopimazine

Crystalline forms of phthalazinone compound

Ivosidenib forms and pharmaceutical compositions

Method for producing crystal of uracil compound

Synthesis of a monoacylglycerol lipase inhibitor

SOLID FORMS OF AN N-TERMINAL DOMAIN ANDROGEN RECEPTOR INHIBITOR AND USES THEREOF

Purified Detomidine, Process of Preparing and Methods of Use

Crystals of hydroxychloroquine sulfate

PROCESS FOR PRODUCING TCA CYCLE INTERMEDIATE CONJUGATES

Vidofludimus for use in the treatment or prevention of viral diseases

Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or pharmaceutically acceptable salt, hydrate, or solvate thereof

Dodecyl sulfate-doped poly(3,4-ethylenedioxythiophene) film and manufacturing method therefor

ANTI-HUMAN PD-1 ANTIBODY CRYSTALS AND METHODS OF USE THEREOF

Crystals of glycyrrhizic acid derivatives, crystalline compositions, pharmaceutical compositions and uses thereof

Benzene 1,4-bis(bisphosphonic acid)-based metal complexes, method of synthesis and applications thereof

Method for preparing gadobutrol

Crystal form of morpholino quinazoline compound, preparation method therefor and use thereof

Salt of LSD1 inhibitor and a polymorph thereof

Tramadol HBR-Celecoxib Co-Crystal

Solid state forms of Omecamtiv mecarbil and Omecamtiv mecarbil diHCl

(+)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine or pharmaceutically acceptable salts thereof, a process for preparation thereof and uses thereof

Crystalline Forms of N1-(1-Cyanocycloproply)-N2-((1S)-1-{4'-[(1R-2,2-Difluoro-1-Hydroxyethyl]Biphenyl-4-YL}-2,2,2-Trifluoroethyl)-4-Fluoro-L-Leucinamide

Solabegron zwitterion and uses thereof

H2O CRYSTAL FORMS OF A TCA CYCLE INTERMEDIATE CONJUGATE

Method for preparing 2-tert-butyl-4-methoxyphenol and new crystal form thereof

Production method for crystal of reduced coenzyme Q10 having excellent stability

POLYMORPHIC COMPOUNDS AND USES THEREOF

Sodium Salt Of N-((1,2,3,5,6,7-Hexahydro-S-Indacen-4-Yl) Carbamoyl) -1 -Isopropyl-1 H-Pyrazole-3-Sulfonamide

SPECIFICALLY-SHAPED CRYSTAL OF COMPOUND AND METHOD FOR PRODUCING SAME

Method of manufacturing a pharmaceutical composition

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Maleate salt of benzothiophene compound, crystalline form thereof, and use thereof

Diacylglycerol acyl transferase 2 inhibitors

Process for Manufacture of (S)-N-(3-((2-((4-((1-acetylpyrrolidin-3-yl)(methyl)amino)phenyl)amino)-5-methoxypyrimidin-4-yl)oxy)phenyl)acrylamide, and Formulations Thereof

Pharmaceutical salts of pyrimidine derivatives and method of treating disorders

Solid state forms of ivosidenib

Solid forms of a Cot inhibitor compound

Elafibranor salts

N-palmitoyl-D-glucosamine in a micronized form

Solution phase synthesis of beta-turn peptidomimetic cyclic salts

Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof

SOLID STATE FORMS OF IXAZOMIB CITRATE

Crystalline forms of cabotegravir sodium

Methods for crystallization of drugs

Pharmaceutical composition comprising N-(3-((2-((3-fluoro-4-(4-methylpiperazin-1-yl phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)phenylacrylamide

Solid State Forms of an Apoptosis-Inducing Agent and Processes Thereof

Crystalline forms of a LTA4H inhibitor

Crystalline form of N-[1-(5-cyano-pyridin-2-ylmethyl)-1 H-pyrazol-3-yl]-2- [4-(1-trifluoromethyl-cyclopropyl)-phenyl-acetamide

CRYSTALLINE FORMS OF ARN-509, PREPARATION METHOD AND USE THEREOF

Etoricoxib solvates and preparation method thereof

Salts of an LSD1 inhibitor and processes for preparing the same

STABLE POLYMORPHIC COMPOSITIONS OF BREQUINAR SODIUM AND METHODS OF USE AND MANUFACTURE THEREOF

Crystalline N-methyl tryptamine derivatives

Crystal form of key intermediate of bruton tyrosine kinase (BTK) inhibitor and preparation method thereof

Drug crystallization under microgravity conditions

Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH

TWO-DIMENSIONAL PEROVSKITES FOR STABLE AND EFFICIENT PHOTOVOLTAIC CELLS

Crystal polymorph of 8-bromo-2-(1-methylpiperidin-4-ylamino)-4-(4-phenoxyphenylamino)pyrido[4,3-d]pyrimidin-5(6H)-one hydrochloride and method for preparing same

2-(1H-indazol-3-yl)-3H-imidazo[4,5-C]pyridines and their anti-inflammatory uses thereof

Treatment of osteoarthritis

Crystalline forms of ozanimod and processes for preparation thereof

Stable polymorphic compositions of brequinar sodium and methods of use and manufacture thereof

Crystalline forms of psilacetin

Polymorphic forms of Belinostat and processes for preparation thereof

Crystalline dipeptides useful in the synthesis of elamipretide

Crystalline 2-fluoro-3-nitrotoluene and process for the preparation thereof

Process for the preparation of 2,2′,2″-(10-((2R,3S)-1,3,4-trihydroxy butan-2-yl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl) triacetic acid and its complexes

SYNTHESIS OF TRANS-8-CHLORO-5-METHYL-1 -[4-(PYRIDIN-2-YLOXY)-CYCLOHEXYL]-5,6-DIHYDRO-4H-2,3,5,10B-TETRAAZA-BENZO[E]AZULENE AND CRYTALLINE FORMS THEREOF

Naphthyridinone derivatives and their use in the treatment of arrhythmia

Salt and crystal form of modified andrographolide compound and preparation method thereof

PROCESS FOR SYNTHESIZING 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)-PYRIDIN-3-YL)METHOXY)BENZALDEHYDE

Method for manufacturing calteridol

Highly stable crystalline Eltrombopag monoethanolamine salt form D1

CRYSTAL OF POLYMYXIN B1 SULFATE, POLYMYXIN B2 SULFATE OR THEIR MIXTURE AND PREPARATION METHOD THEREOF

Pharmaceutical compositions of lipoic acid choline ester salts and methods of treatment using same

Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and l-leucine ethyl ester

Diarylpyrazole compound, composition comprising same, and use thereof

FORMULATIONS OF PIMAVANSERIN

Cocrystal of progesterone and preparation method and use thereof

NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS

Scalable polypropionate lactone stereotetrads

Process for the preparation of Remimazolam and solid state forms of Remimazolam salts

Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt

Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt

Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt

Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and amino ethyl esters

Crystal of pyrido[3,4-d]pyrimidine derivative or solvate thereof

CRYSTAL FORMS OF THIAZOLE COMPOUND AND APPLICATION THEREOF

Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-n,2-dimethylbenzofuran-3-carboxamide

Method for preparing voriconazole L-camphorsulphonate and voriconazole

Crystal habit of quinoline derivative and preparation method for crystalline powder thereof

Method for preparing escitalopram bis-hydroxynaphtoate crystal form a

METHOD FOR MANUFACTURING CALCOBUTROL

2,3,5-trimelthyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders

Methods of treating APOL-1 dependent focal segmental glomerulosclerosis

Hydrate crystal of 3′,3′-cGAMP

Cycloalkane-1,3-diamine derivative

FORMS OF A PI3K DELTA SELECTIVE INHIBITOR FOR USE IN PHARMACEUTICAL FORMULATIONS

Crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleucine ethyl ester

PHARMACEUTICALLY ACCEPTABLE SALTS OF SEPIAPTERIN

Crystal form as ASK1 inhibitor and preparation method and application thereof

Crystalline hydrate of a JAK inhibitor compound

Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Solid forms of an azolopyrimidine compound

Crystal form of 4-phenylthiazole derivative and preparation method thereof

Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof

Polymorphic forms of RAD1901-2HCl

Process for the Preparation of Obeticholic Acid and Intermediates Used In the Process Thereof

Titanium heterometallic metal-organic solids, method for obtaining them and their uses

CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF

SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS

Polymorphs

Crystal form of compound for inhibiting the activity of CDK4/6 and use thereof

SALTS OF (S)-(5-CYCLOBUTOXY-2-METHYL-6-(1-(PIPERIDIN-4-YL)-1H-PYRAZOL-4-YL)-3,4-DIHYDROQUINOLIN-1(2H)-YL)(CYCLOPROPYL)METHANONE AND SOLID FORMS THEREOF

Crystalline forms of 1-(4-{[6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl}-4-fluoro-piperidin-1-yl)-propenone, salt forms thereof, and processes to obtain

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

Crystalline solid forms of salts of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1, 1-dicarboxamide, processes for making, and methods of use

Crystalline Form of Fluopyram

CRYSTAL OF AMINO ACID SALT OF 3-HYDROXYISOVALERIC ACID AND PRODUCTION METHOD THEREOF

CRYSTALLINE FORMS OF (-)-(1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL)-PHENOL HYDROCHLORIDE

Heterocyclic compounds, preparation methods and uses thereof

Phosphate of platinum compound and preparation method therefor

SALTS AND SOLID FORMS AND PROCESSES OF PREPARING A PI3K INHIBITOR

Solid forms of (R)-N-(2-(5-fluoropyridin-3-yl)-8-isopropylpyrazolo[ 1,5-a][1,3,5]triazin-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-amine maleate as aryl hydrocarbon receptor (AHR) inhibitors

Solid forms of {6-[(2-amino-3-chloropyridin-4-yl)sulfanyl]-3-[(3S,4S)-4-amino-3-methyl-2-oxa-8- azaspiro[4.5]decan-8-yl]-5-methylpyrazin-2-yl} methanol, a SHP2 inhibitor

Method for preparing 2-[(3R)-3-methylmorpholin-4-yl]-4-[1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridine

AMORPHOUS AND CRYSTALLINE FORMS OF VALBENAZINE SALT

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

Crystalline polymorphs of Rivoceranib and Rivoceranib mesylate

Crystalline Eravacycline Bis-Hydrochloride

Solid forms of berberine ursodeoxycholate and compositions and methods thereof

Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

NOVEL FORM OF BARDOXOLONE METHYL

Crystal form of lanosterol prodrug compound and application thereof

Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

SOLID FORMS OF APOL1 INHIBITOR AND METHODS OF USING SAME

Crystalline forms of 4-(tert-butoxyamino)-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazin-2-amine

Synthesis of tipifarnib

Process for the preparation of Lenvatinib

Process for synthesis and purification of (2R,6R)-hydroxynorketamine

NOVEL CRYSTALLINE FORMS OF SELINEXOR AND PROCESS FOR THEIR PREPARATION

Crystalline polymorphs of a muscarinic acetylcholine receptor agonist

Crystal forms of thiophene derivatives

Crystal forms of an ALK2 inhibitor

Crystalline forms of (S)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]pyridazine-7-yl)ethyl)amino)pyrimidine-5-carbonitrile as inhibitors of phosphatidylinositol-3-kinase

CRYSTALLINE FORMS OF 3-((1R,5S,9r)-9-ETHOXY-3-AZABICYCLO[3.3.1]NONAN-9-YL)-BENZAMIDE AND SALT FORMS THEREOF

SOLID STATE FORMS OF VENETOCLAX AND PROCESSES FOR PREPARATION OF VENETOCLAX

Crystal form of c-MET inhibitor and salt form thereof and preparation method therefor

Method for improving nucleation of crystals from solution

Pharmaceutical formulation of odevixibat

ARAMCHOL SALTS

Methods of synthesizing substituted purine compounds

Crystal form of tri-cycle compound and application thereof

Process for preparing substituted polycyclic pyridone derivative and crystal thereof

Crystal forms of thiophene derivatives

INHIBITORS OF RORgamma

Addition salt of S1P1 receptor agonist and crystal form thereof, and pharmaceutical composition

Crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-1,2,4-oxadiazol-3-yl)benzoic acid and processes for their preparation

Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione monohydrate, compositions and methods of use thereof

Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereof

Processes for preparing (E)-(2-(chloromethyl)-3-fluoroallyl) carbamate compounds

Cocrystals of ubiquinone and compositions comprising them

IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS

Solid forms of substituted benzoxaborole and compositions thereof

Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1H-pyrazolo[3,4-D]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile

Process for making beta 3 agonists and intermediates

Mixed-valence crystal superstructures

CRYSTALLINE COMPOUNDS AND METHODS OF MAKING THE SAME

AMORPHOUS FORMS OF SELINEXOR AND PROCESS FOR THEIR PREPARATION

Salts and crystal forms of omecamtiv mecarbil

CRYSTALLINE FORMS OF 1-(ACYLOXY)-ALKYL CARBAMATE DRUG CONJUGATES OF NAPROXEN AND PREGABALIN

Crystalline forms of zuclomiphene citrate

Non-solvate crystal of eucomic acid and method for producing same

Crystalline salt comprising 5-methyl-(6S)-tetrahydrofolic acid and 4-(2-hydroxyethyl)-morpholine

Methods

Crystalline form of phenyl bis (2,4,6-trimethylbenzoyl) phosphine oxide with large particle size and crystallization method for making same

CDK4/6 INHIBITOR AND PHARMACEUTICALLY ACCEPTABLE SALT AND POLYMORPH THEREOF AND USE THEREOF

Salt form

Salt form

Pyrimidine compound as JAK kinase inhibitor

Crystal form of tipifarnib and method of treatment thereof

Method for preparing lenalidomide

Method for producing 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)propan-2-ol

Crystalline form of s-apomorphine

Crystal form of lenvatinib mesylate and preparation method therefor

Crystalline epinephrine malonate salt

(Thio)nicotinamide ribofuranoside salts and compositions, methods of making, and uses thereof

Crystalline forms of a TLR7/TLR8 inhibitor

Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4,4-dimethylpent-2-enenitrile

Co-Crystal of an Orally Available Janus Kinase Inhibitor

NAPHTHYRIDINES AS INTEGRIN ANTAGONISTS

Crystal form and salt form of pyridone compound and preparation method therefor

Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan

Crystalline form of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-D3) pyridazine-3-carboxamide

Processes for preparing a diaminopyrimidine derivative or acid addition salt thereof

Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide

Crystalline form of ethyl 2-[2-[2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy]phenoxy]acetate

Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide

Angiotensin II receptor 2 antagonist salt form and crystalline form, and preparation method therefor

Crystalline solid forms of N-{4-[(6,7-Dimethoxyquinolin-4-yl)oxy]phenyl} -n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use

UREA DERIVATIVE

Process for making solid methylglycine diacetate (MGDA) alkali metal salt, and solid particles

AXL kinase inhibitors and use of the same

MRSA biofilm inhibition

Salts of compounds and crystals thereof

Salt of fused ring pyrimidine compound, crystal form thereof and preparation method therefor and use thereof

Crystal form of tenvermectin B, preparation method therefor, and use thereof

Crystal form of 1H-imidazo[4,5-b]pyridine-2(3H)-one compound and preparation process therefor

FUMARATE SALT OF 5-((5-METHYL-2-((3,4,5-TRIMETHYLPHENYL)AMINO)PYRIMIDIN-4-YL)AMINO)-BENZO[D]OXAZOL-2(3H)-ONE

Substituted tetrahydrofurans as modulators of sodium channels

Crystals of cyclic amine derivative and pharmaceutical use thereof

Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same

Crystalline Eltrombopag monoethanolamine salt form D

Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use

Amine salt of obeticholic acid

Crystalline form of gemcitabine

Crystal form of ACP-196 and method of treatment thereof

CRYSTAL FORM OF HYDROCHLORIDE OF PYRAZOLOHETEROARYL DERIVATIVE AND PREPARATION METHOD

Solid forms of an sGC stimulator

Capsid inhibitors for the prevention of HIV

EZH2 INHIBITOR AND PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHIC SUBSTANCES THEREOF, AND APPLICATION OF EZH2 INHIBITOR

Crystalline forms of 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide

Polymorphs of 4-[3-chloro-4-(n′-cyclopropyl ureido)phenoxy] -7-methoxyquinoline-6-carboxamide, its salts and process for the preparation thereof

Process for the preparation of Cabozantinib and its pharmaceutically acceptable salts thereof

NOVEL POLYMOPHS OF S-NITROSOCAPTOPRIL (CAP-NO) AND ITS PROCESS FOR PREPARATION

Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use

Efficient crystallization process for preparing ultrapure Treprostinil and crystal prepared therefrom

Substituted oxadiazole chemical compound and composition containing said chemical compound and use thereof